Alfresa Holdings Corporation Share Price
Stocks
2784
JP3126340003
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Japan Exchange
12:00:00 23/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,406.50 JPY | +1.45% |
|
+3.26% | -1.01% |
| 05/10 | Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL | MT |
| 01/07 | Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation | CI |
| Market Cap | 42TCr 269.21Cr 240.4Cr 222.08Cr 201.26Cr 376.53Cr 26TCr 382.76Cr 2.67TCr 1.06TCr 13TCr 1.01TCr 988.82Cr | P/E 2027 * |
18.2x | P/E 2028 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 42TCr 269.21Cr 240.4Cr 222.08Cr 201.26Cr 376.53Cr 26TCr 382.76Cr 2.67TCr 1.06TCr 13TCr 1.01TCr 988.82Cr | EV / Sales 2027 * |
0.13x | EV / Sales 2028 * | 0.13x |
| Free-Float |
88.98% | Yield 2027 * |
2.95% | Yield 2028 * | 3.31% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 2784 | Delayed | |
OTC Markets
| ARHCF | Delayed |
| 1 day | +1.45% | ||
| 1 week | +3.26% | ||
| Current month | +5.73% | ||
| 1 month | +2.27% | ||
| 3 months | +3.84% | ||
| 6 months | +1.28% | ||
| Current year | -1.01% |
| 1 week | 2,331 |  | 2,439 |
| 1 month | 2,210 | | 2,439 |
| Current year | 2,106.5 | | 2,685.5 |
| 1 year | 2,106.5 | | 2,685.5 |
| 3 years | 1,897 | | 2,685.5 |
| 5 years | 1,505 | | 2,685.5 |
| 10 years | 1,505 | | 3,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
CEO | Chief Executive Officer | 63 | - |
Watase Maiko
ADM | Chief Administrative Officer | - | - |
Toshiki Tanaka
CTO | Chief Tech/Sci/R&D Officer | 63 | 28/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
BRD | Director/Board Member | 63 | 01/06/2007 |
Yuji Ueda
BRD | Director/Board Member | 65 | 25/06/2025 |
Yusuke Fukujin
BRD | Director/Board Member | 50 | 01/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.45% | +3.26% | +10.16% | +0.94% | 269.21Cr | |
| +1.16% | -1.13% | -17.92% | +8.27% | 18TCr | |
| +0.02% | +4.24% | -19.82% | +16.53% | 12TCr | |
| -1.22% | +0.70% | +1.27% | +31.80% | 12TCr | |
| +2.29% | +17.36% | -41.94% | +9.49% | 9.33TCr | |
| -2.21% | -2.91% | +0.74% | +75.30% | 6.32TCr | |
| -1.06% | +1.75% | +13.50% | +80.00% | 5.57TCr | |
| -0.75% | +3.73% | +6.64% | -22.28% | 5.42TCr | |
| -1.13% | +0.00% | -12.25% | +31.02% | 4.41TCr | |
| +0.17% | +5.85% | -4.92% | -10.64% | 3.4TCr | |
| Average | -0.13% | +3.57% | -6.45% | +22.04% | 7.61TCr | |
| Weighted average by Cap. | +0.00% | +3.09% | -11.61% | +22.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 3,19400Cr 2.04TCr 1.82TCr 1.68TCr 1.52TCr 2.85TCr 1,93400Cr 2.9TCr 20TCr 8.01TCr 1,01300Cr 7.64TCr 7.48TCr | 3,28900Cr 2.1TCr 1.87TCr 1.73TCr 1.57TCr 2.93TCr 1,99100Cr 2.98TCr 21TCr 8.24TCr 1,04300Cr 7.87TCr 7.7TCr |
| Net income | 2.34TCr 15Cr 13Cr 12Cr 11Cr 21Cr 1.42TCr 21Cr 148.23Cr 59Cr 742.66Cr 56Cr 55Cr | 2.71TCr 17Cr 15Cr 14Cr 13Cr 24Cr 1.64TCr 25Cr 171.88Cr 68Cr 861.12Cr 65Cr 64Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | JP¥2,406.50 | +1.45% | 4,97,700 |
| 22/26/22 | JP¥2,372.00 | +0.89% | 4,71,100 |
| 21/26/21 | JP¥2,351.00 | +0.13% | 4,57,000 |
| 20/26/20 | JP¥2,348.00 | +0.26% | 2,33,800 |
| 19/26/19 | JP¥2,342.00 | +0.49% | 4,23,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2784 Stock
Select your edition
All financial news and data tailored to specific country editions
